Cargando…
Profiling ovarian cancer tumor and microenvironment during disease progression for cell-based immunotherapy design
Ovarian cancer (OC) is highly lethal due to late detection and frequent recurrence. Initial treatments, comprising surgery and chemotherapy, lead to disease remission but are invariably associated with subsequent relapse. The identification of novel therapies and an improved understanding of the mol...
Autores principales: | Li, Yan-Ruide, Ochoa, Christopher J., Zhu, Yichen, Kramer, Adam, Wilson, Matthew, Fang, Ying, Chen, Yuning, Singh, Tanya, Di Bernardo, Gabriella, Zhu, Enbo, Lee, Derek, Moatamed, Neda A., Bando, Joanne, Zhou, Jin J., Memarzadeh, Sanaz, Yang, Lili |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558812/ https://www.ncbi.nlm.nih.gov/pubmed/37810241 http://dx.doi.org/10.1016/j.isci.2023.107952 |
Ejemplares similares
-
Exploring the Potential of Drug Response Assays for Precision Medicine in Ovarian Cancer
por: Singh, Tanya, et al.
Publicado: (2020) -
Efficacy of birinapant in combination with carboplatin in targeting platinum-resistant epithelial ovarian cancers
por: Singh, Tanya, et al.
Publicado: (2022) -
Advancements in CRISPR screens for the development of cancer immunotherapy strategies
por: Li, Yan-Ruide, et al.
Publicado: (2023) -
Graft-versus-Host Disease Modulation by Innate T Cells
por: Fang, Ying, et al.
Publicado: (2023) -
A rare case of vulvar extraskeletal myxoid chondrosarcoma: mimics and diagnostic clues
por: Liou, Sofia S., et al.
Publicado: (2021)